Last reviewed · How we verify
NCT05903430: MIDSECTION
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)
trial in Abdominal Cancer in 60 participants. Currently enrolling.
29 January 2027
Quick facts
| Lead sponsor | The Christie NHS Foundation Trust |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 29 August 2025 |
| Primary completion | 29 January 2027 |
| Estimated completion | 29 January 2027 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Abdominal Cancer — all drugs for Abdominal Cancer →
- Lung Cancer — all drugs for Lung Cancer →
Sponsor
The Christie NHS Foundation Trust
Who can join
18 and older, any sex, with Abdominal Cancer or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if the investigators are able to deliver highly focused, intense radiation to tumours in the abdominal region or chest cavity whilst limiting the dose to surrounding organs using a high field strength MR-Linac.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Harnessing the Power of Radiotherapy for Lung Cancer: A Narrative Review of the Evolving Role of Magnetic Resonance Imaging Guidance.
Cheng SH, Lee SY, Lee HH. · · 2024 · cited 3× · PMID 39123438 · DOI 10.3390/cancers16152710
Verify or expand the search:
- PubMed search for NCT05903430
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Cancer
Currently open trials in the same condition.
- NCT05219058 — Reconstruction in Extended MArgin Cancer Surgery · recruiting
- NCT00493688 — A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes · recruiting
Other The Christie NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07183267 — Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Year · NA · not yet recruiting
- NCT07268339 — A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calme · Phase 3 · not yet recruiting
- NCT06965101 — To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compr · NA · recruiting
- NCT07202260 — Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung · active not recruiting
- NCT06804447 — Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05903430 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Christie NHS Foundation Trust
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05903430.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing